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Abstract
Objective—To estimate gestational-age-specific risks of fetal death in pregnancies complicated 
by preeclampsia.
Methods—Population-based cohort study comprising all singleton births (N=554,333) without 
preexisting chronic hypertension recorded in the Norwegian Medical Birth Registry from 
1999-2008. Additional data come from a subset of preeclamptic pregnancies enrolled in the 
Norwegian Mother and Child Cohort Study with available medical records (N=3037). The risk of 
fetal death, expressed per 1,000 fetuses exposed to preeclampsia, was calculated using a life-table 
approach.
Results—Preeclampsia was recorded in 3.8% (n=21,020) of all pregnancies. Risk of stillbirth 
was 3.6/1000 overall and 5.2/1000 among pregnancies with preeclampsia (relative risk (RR) 
=1.45, 95% confidence interval (CI) =1.20 to 1.76). However, relative risk of stillbirth was 
markedly elevated with preeclampsia in early pregnancy. In week 26 there were 11.6 stillbirths per 
1000 pregnancies with preeclampsia, compared with 0.1 stillbirth per 1000 pregnancies without, 
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relative risk 86 (95% CI=46 to 142). Fetal risk with preeclampsia declined as pregnancy advanced, 
but at 34 weeks remained more than sevenfold higher than pregnancies without preeclampsia.
Conclusion—For clinical purposes, the fetal risk of death associated with preeclampsia begins 
when preeclampsia becomes clinically apparent. Using a method that takes into account the 
clinical diagnosis of preeclampsia and the population of fetuses at risk, we find a remarkably high 
relative risk of fetal death among pregnancies diagnosed with preeclampsia in the preterm period.
INTRODUCTION
Preeclampsia, a pregnancy-related condition characterized by hypertension and proteinuria, 
is associated with increased fetal death.(1,2) Preeclampsia arising in the preterm period is of 
particular concern because it is generally considered to be more dangerous to both the 
mother and fetus.(3) Paradoxically, efforts to quantify the risk of stillbirth at each gestational 
week often suggest that the risk with preeclampsia (compared with normotensive 
pregnancies) is greater at term than at preterm.(1,4-6)
While the pathological origins of preeclampsia likely occur during placentation, the clinical 
signs and symptoms typically do not emerge until after 20 weeks gestation.(7) The most 
relevant estimate of fetal risk in the presence of preterm preeclampsia would be one that 
considers the timing of preeclampsia diagnosis – a diagnosis that often occurs well before 
the time of delivery. Detailed clinical records to determine the week in which preeclampsia 
is diagnosed are seldom available for the large study populations required to estimate fetal 
mortality. We used data from the Medical Birth Registry of Norway, supplemented by 
detailed antenatal records from a subset of those births, to estimate gestational-week-specific 
fetal mortality in the presence of preeclampsia.
MATERIALS AND METHODS
The Medical Birth Registry of Norway records all live births and fetal deaths after 12 weeks 
of gestation.(8) We selected for analysis all singletons born from 1999 through 2008 to 
mothers with no registered diagnosis of pre-existing hypertension (n = 564,753). We 
restricted analysis to pregnancies lasting at least 24 completed weeks but no longer than 42 
weeks based on routine early ultrasound for 98% of all deliveries(9) and last menstrual 
period for the remainder. To avoid large errors in gestational age, we excluded infants with 
gestational-age-specific birth weights more than 5 standard deviations above the mean.(10) 
These several criteria excluded 2% of births, leaving 554,333 pregnancies for analysis. 
Review of the antenatal charts was carried out in accordance with the Medical Birth 
Registry regulation(11) and received appropriate ethical review and approval from the 
Medical Birth Registry of Norway and the University of North Carolina. The Medical Birth 
Registry of Norway approved the use of de-identified data for this analysis.
In Norway, pregnant women carry an antenatal card to each prenatal visit, where a midwife 
or physician records blood pressure and proteinuria. A separate study was conducted within 
the Medical Birth Registry to validate the registration of preeclampsia for preeclamptic 
pregnancies recorded during 1999-2008.(11) This validation study made use of prenatal 
records requested for all 3800 preeclamptic pregnancies that were part of the Norwegian 
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Mother and Child Cohort Study (MoBa), a national birth cohort of 113,000 pregnancies 
recruited early in pregnancy during 1999-2008.(12) After attrition imposed by non-response, 
inadequate records, and our strict criteria for defining first diagnosis (see end of paragraph 
and Appendix 1, available online at http://links.lww.com/xxx), we could assign a week of 
diagnosis for 1857 (61%) of those preeclamptic pregnancies. We used this subset of 1857 to 
estimate the distribution of timing of preeclampsia diagnosis for all 21,020 preeclamptic 
pregnancies in the registry during the corresponding ten-year period. To receive a diagnosis 
of preeclampsia, both hypertension (systolic blood pressure ≥140mmHg or diastolic blood 
pressure ≥90mmHg) and proteinuria (≥1+ protein) had to be present at the same visit.(7) 
These criteria reflect the clinical definition of preeclampsia during the years of data 
collection.
Clinical diagnosis strictly requires that hypertension be documented twice. However, 
women with rapidly emerging symptoms may be transferred directly from the antenatal site 
to the hospital for confirmation of the disease, so that two measures may not be present in 
prenatal records for true cases. All cases in the subset received a diagnosis of preeclampsia 
in the Medical Birth Registry of Norway, suggesting that the criterion of a second measure 
had been met by the time of hospital discharge – even if documented only once in the 
antenatal records (which were limited to visits outside the hospital). Accordingly, we used 
the first visit where criteria were met as the gestational age of diagnosis.
Given that preeclampsia is frequently diagnosed at a routine prenatal clinic visit, even 
though signs of preeclampsia may have been present for some time during the interval since 
the previous prenatal visit, we defined the time of diagnosis, for purposes of analysis, as a 
time halfway between the prenatal visit of first diagnosis and the previous visit. Prenatal 
care in Norway is provided free of charge to all pregnant women and is widely attended,(13) 
which reduces potential bias from late entry into prenatal care or from infrequent care. In 
this population, women who eventually developed preeclampsia had a median of 2 weeks 
between visits until 30 weeks gestation and 1 week between visits after 30 weeks. Details on 
data collection, definitions, and exclusions are provided in Appendix 1 (http://
links.lww.com/xxx).
The subset of women with known time of preeclampsia diagnosis provided a distribution of 
preeclampsia cases diagnosed in each gestational week, which we then applied to the larger 
sample of 21,020 preeclamptic pregnancies in the registry to determine the number of new 
pregnancies at risk each week for the whole population. An example of this calculation can 
be found in Table 1 (Column D).
The risk of stillbirth in a specific week of pregnancy is often expressed as a proportion of the 
number of births in a specific week.(14) Such calculations do not express the risk in terms of 
the population actually at risk, namely all fetuses at that gestational age. Instead, we 
calculate the weekly risk of fetal death as a proportion of all fetuses (all pregnancies) in that 
week, which is the true population at risk. We constructed a life table enumerating 
pregnancies with and without preeclampsia at the beginning of each gestational week. New 
cases of preeclampsia (i.e., those projected to occur each week based on the distribution of 
diagnosis in the subset) are transferred from the unexposed risk-set to the preeclampsia risk-
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set. Deliveries are removed each week from their respective risk-sets (both stillbirths and 
live births). The full life table with examples of the calculations used is provided in Table 1.
From this life table we estimated the number of ongoing preeclamptic pregnancies in each 
week, which we then used to estimate the week-specific risk of fetal deaths in pregnancies 
with and without preeclampsia. We smoothed the mortality data using a three-week moving 
average (geometric means), and calculated relative risks from the smoothed data. 
Confidence intervals were estimated using resampling to incorporate the variability in the 
estimated distribution of preeclampsia diagnosis.(15) We provide a full description of the 
analytic methods in Appendix 2, available online at http://links.lww.com/xxx.
RESULTS
There were 554,333 eligible singleton pregnancies delivered in Norway in 1999-2008, of 
which 3.8% (n=21,020) had preeclampsia recorded at delivery. Maternal and fetal 
characteristics of pregnancies with and without preeclampsia are presented in Table 2. 
Maternal age was similar in the two groups. Preeclamptic women were slightly less likely to 
be smokers and more likely to be nulliparous, as commonly seen in other studies.(16)
The subset of 1857 pregnancies with known week of preeclampsia diagnosis were similar to 
the total population with preeclampsia (Table 2) although, the subset had slightly more 
nulliparous women (66% versus 60%) and non-smoking women (76% versus 71%).
Adjusted for time between prenatal visits, 8% of preeclampsia cases had been diagnosed by 
the end of week 28, 36% by the end of week 34, and 71% by the end of week 37. Median 
diagnosis of preeclampsia was at 36 weeks, with 10th and 90th percentiles at 29.5 and 39.5 
weeks.
The risk of stillbirth was 3.6/1000 overall, and 5.2/1000 among pregnancies with 
preeclampsia (relative risk (RR) =1.45, 95% confidence interval (CI) =1.20 to 1.76). In 
pregnancies with no preeclampsia, the weekly risk of fetal death was extremely low – on the 
order of 0.1 to 0.9 deaths per 1000 pregnancies per week up to 40 weeks (Figure 1). In 
contrast, the risk of fetal death among pregnancies with preeclampsia was 11.6 per 1000 in 
week 26, 4.6 per 1000 in week 28, and 2.5 per 1000 in week 32. The corresponding relative 
risks are 86 in week 26, 36 in week 28, and 19 in week 32 (Table 3). All confidence 
intervals excluded the null expectation by a wide margin. A stratified analysis of first births 
using the distribution of preeclampsia diagnosis observed among first births in the subset, 
resulted in a very similar magnitude and pattern of relative risk (Appendix 3, available 
online at http://links.lww.com/xxx).
Our estimates of fetal risk depend on the accurate timing of preeclampsia diagnosis (derived 
from prenatal records). Any error that underestimates the proportion with early-onset 
preeclampsia would reduce the denominator in a given preterm week and thus inflate fetal 
risk. Similarly, overestimating the proportion with early onset would underestimate early 
fetal risk.
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Our estimate of time of preeclampsia diagnosis excluded pregnancies that did not meet our 
clinical definition of preeclampsia based on prenatal records (i.e., before being admitted to 
hospital for delivery). By default, such exclusion assumes those pregnancies had the same 
average time of diagnosis as other preeclamptic pregnancies. In a sensitivity analysis, we 
made the extreme alternative assumption, that preeclampsia in these pregnancies emerged as 
late as possible (i.e. on the day of delivery). As expected, this shift to diagnosis in later 
weeks reduced the estimated prevalence of preeclampsia in earlier weeks and increased the 
estimated fetal risk with preterm preeclampsia (see Appendix 1 and Appendixes #4 and #5, 
all available online at http://links.lww.com/xxx, for detailed methods and results).
DISCUSSION
Clinicians are aware of the increased risk of fetal death among pregnancies diagnosed with 
preeclampsia in the preterm period. Efforts to quantify this risk, however, have 
paradoxically suggested that highest relative risk of fetal death with preeclampsia is during 
the term period.(1,4-6) We address this question in a novel way, by estimating the risk of 
fetal death at each gestational week given the estimated presence (or absence) of 
preeclampsia in that week. While the baseline risk of fetal death in a given week is low, fetal 
risk with preeclampsia was 86-fold higher in week 26, almost 50-fold higher in week 27, 
and more than 35-fold higher in week 28. Even in week 34, fetal risk was increased more 
than 7-fold. This elevated fetal risk is plausibly due to the disorders of placental function 
that cause preeclampsia,(17) or to systemic maternal responses to inadequate placentation.
The week-specific risk of fetal death with early preeclampsia is difficult to estimate for at 
least three reasons. First, very large study populations are required. The exposure and 
outcome are both rare, and the absolute risk remains small. To accurately measure risk, we 
assembled data on all Norwegian births over a 10-year period – and even then, estimates 
within gestational-age strata were limited by small numbers.
A second obstacle to the estimation of fetal risk with preeclampsia is the inaccessibility of 
information on time of preeclampsia diagnosis. To assume that preeclampsia is present early 
in all pregnancies subsequently diagnosed would drastically underestimates fetal risk at 
early gestational ages by inflating the weekly population at risk. We were able to estimate 
time-ofpreeclampsia diagnosis by taking advantage of data from a special study of nearly 
nineteen hundred women with incident preeclampsia, a subset that could reasonably be 
extrapolated to the whole population of preeclamptic pregnancies.
A third issue in estimating fetal risk lies in the definition of fetal mortality. We defined fetal 
risk in relation to all fetuses present at a given gestational week. This approach is rational 
but (for historical reasons) not standard. The more common definition of stillbirth risk in 
vital statistics and elsewhere has been the number of stillbirths divided by the number of all 
births (stillbirths plus live births).(14) While this risk measure is informative when applied 
to the overall stillbirth rate, it has dubious clinical relevance when applied to specific 
gestational weeks. This problem has been recognized since at least 1987, when Yudkin and 
colleagues(18) suggested that the risk of death among all fetuses at a given gestational age is 
the more clinically relevant measure. Yudkin's definition has won acceptance in principle 
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(19-22) and has recently appeared in US vital statistics reports,(23) but has not yet been 
widely applied.
The standard definition of stillbirth rate has another (if more subtle) disadvantage: it is 
vulnerable to strong bias in the presence of unmeasured factors that cause both preterm 
delivery and stillbirth.(24,25) Such unmeasured factors become concentrated in non-
preeclamptic preterm births, making stillbirth appear higher in non-preeclamptic than 
preeclamptic pregnancies.(1,16) This apparent “protective effect” of preeclampsia during the 
preterm weeks has sometimes been misinterpreted as evidence that preeclampsia 
biologically reduces fetal risk during the preterm weeks.(26) Our results show that the 
opposite is true – preterm preeclampsia constitutes a serious threat to the fetus.
Management of severe preeclampsia involves balancing the welfare of the mother and the 
fetus. There is a further dilemma with regard to the fetus, in that early delivery spares further 
risk from fetal death but exposes the preterm infant to the dangers of neonatal morbidity and 
mortality. A recent Cochrane review(27) assessed the fetal consequences of immediate 
versus delayed delivery in pregnancies with “severe preeclampsia” (before 34 weeks). Net 
survival of the fetus (fetal plus neonatal mortality) was similar with immediate or delayed 
delivery (risk ratio with immediate delivery 1.08 (0.69 to 1.71)). While our data may help to 
further quantify fetal risk among women diagnosed with preeclampsia, clinical decision-
making will continue to depend on clinical judgment and the specific clinical picture of each 
mother-and-fetus pair.
Our assessment of fetal risk with preterm preeclampsia was made possible by combining 
data from the Norwegian birth registry with a smaller sample of detailed antenatal charts. 
These two resources combine the strength of population-level data on stillbirths with 
detailed clinical data on the timing of preeclampsia diagnosis for a substantial subset. 
Analyzing these data with a fetuses-at-risk approach(18) quantified a hazard for fetuses in 
preterm preeclamptic pregnancies. The same approach could equally apply to assessment of 
fetal risk with any condition that emerges during pregnancy and persists.
The study has important limitations. One, preeclampsia is incompletely captured by the 
Medical Birth Registry of Norway.(11) Unrecorded cases of preeclampsia, misclassified as 
“non-cases” in our analysis, would tend to reduce our estimates of fetal relative risk. A more 
serious error would be false-positive diagnoses of preeclampsia in the birth registry. 
However, the positive predictive value of preeclampsia registration in the Medical Birth 
Registry of Norway has been estimated at 85% overall and 94% in preterm births.(11) 
Indicators of severity of disease are less reliably recorded.(11) In particular fetal growth 
restriction at the time of diagnosis is not available in the registry and precludes analysis 
among these particularly vulnerable fetuses.
Another limitation is sample size. Even with data from a half-million births, the low rates of 
fetal mortality in Norway produce relatively few stillbirths. It would have been informative 
to stratify our analysis by maternal parity or smoking, but estimates of fetal mortality were 
much less stable in those smaller strata.
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The Medical Birth Registry of Norway lacks information on obesity and other maternal 
factors that might confound analyses of preeclampsia and stillbirth. Given that our main 
finding was a strong gradient of risk across gestational age, it is implausible that adjustment 
for maternal characteristics that are stable across gestational age would alter that conclusion.
There are urgent clinical questions that these data cannot address. Both severity and duration 
of preeclampsia could reasonably be expected to affect the level of fetal risk. The birth 
registry lacks dates of preeclampsia diagnosis and specific features of severe disease at the 
time of diagnosis. Our estimates provide simply the average risk among all preeclamptic 
pregnancies at given gestational weeks.
In sum, our analysis documents the fetal risk that accompanies preeclampsia in early 
pregnancy. While this risk to the fetus is generally recognized, the extent of risk is far higher 
than previously estimated.
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There is a remarkably high relative risk of stillbirth among pregnancies diagnosed with 
preeclampsia in the preterm period.
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Figure 1. Per-week risk of fetal death for pregnancies with and without preeclampsia
Circles and filled squares represent exact risks; darker lines represent three-week moving 
averages; pairs of lighter lines represent 95th percentile intervals.
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TABLE 2
Characteristics of 554,333 women and their infants delivered in Norway in 1999-2008, by presence of 
preeclampsia, together with the subset of 1857 women who provided data on exact date of diagnosis of 
preeclampsia
Norwegian Medical Birth Registry Validation Subset
a
No preeclampsia Preeclampsia Dated Preeclampsia
Total births 533313 21020 1857
Stillbirth 1905 109 7
Stillbirth rate per 1,000 births 3.6 5.2 3.8
Characteristic N % N % N %
Maternal age
<=24 91552 17 4492 21 274 15
25-34 354307 66 13228 63 1275 69
35+ 87416 16 3299 16 308 17
Missing 38 1 0
Parity
0 214336 40 12618 60 1219 66
1 192428 36 5224 25 413 22
2+ 126549 24 3178 15 225 12
Smoking at end of pregnancy
No 360795 68 14856 71 1411 76
Yes 56086 11 1490 7 61 3
Missing 116432 22 4674 22 385 21
Gestational Age at birth (week)
≤26 918 0. 2 165 1 10 1
27-30 1851 0.4 725 3 50 3
31-34 7047 1 1797 9 133 7
35-36 15724 3 2332 11 213 11
37-38 91565 17 5393 26 487 26
39-40 274969 52 7597 36 685 37
41-42 141239 26 3011 14 279 15
Birth weight (g)
<1000 1289 0. 2 491 2 27 1
1000-1999 4396 1 1893 9 138 7
2000-2999 59891 11 5419 26 504 27
3000-3999 354388 66 10051 48 930 50
4000+ 112682 21 3140 15 258 14
Missing 667 0.1 26 0.1 0
Timing of fetal death
Before onset of labor 1522 80 88 81 6 86
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Norwegian Medical Birth Registry Validation Subset
a
No preeclampsia Preeclampsia Dated Preeclampsia
During delivery 131 7 6 6 0
Unknown 252 13 15 14 1 14
Neonatal Death
b 843 0.16 71 0.34 2 0.11
a
Subset of pregnancies with preeclampsia identified in the Norwegian Medical Birth Registry and with an identified date of diagnosis in a 
validation study using prenatal records.
b
Deaths in first 28 days following birth expressed per 100 live births.
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Table 3




 week-specific risk of fetal death per 1,000 ongoing pregnancies
Week Preeclampsia No Preeclampsia Relative Risk 95% Confidence Interval
b
25 10.7 0.16 69 33 to 120
26 11.6 0.14 86 46 to 142
27 6.5 0.13 49 24 to 83
28 4.6 0.13 36 17 to 61
29 2.6 0.11 23 10 to 38
30 3.1 0.12 27 13 to 42
31 2.7 0.13 22 11 to 33
32 2.5 0.13 19 10 to 28
33 1.8 0.14 13 6.5 to 19
34 1.1 0.15 7.3 3.3 to 11
35 0.8 0.18 4.4 1.9 to 6.8
36 0.8 0.21 3.7 1.7 to 5.4
37 0.9 0.28 3.2 1.6 to 4.4
38 1.1 0.36 3.0 1.7 to 4.1
39 1.0 0.54 1.9 0.9 to 2.7
40 1.6 0.83 1.9 0.9 to 2.7
a
Smoothed using a 3-week running geometric mean
b
95% bootstrap percentile confidence intervals based on 10,000 resamples of the time-of-diagnosis distribution and both live and stillbirth 
distributions conditional on preeclampsia status
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